Researchers from the Boston University School of Public Health in the United States say there is no evidence to support a correlation between ABO blood group and the risk of infection with severe ...
The evolution of breast cancer screening in the Medicare population: Clinical and economic implications. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract does not ...
- ABO-101 was well tolerated with no serious adverse events or dose-limiting toxicities reported in the 28-days following dosing - Phase 1/2 redePHine study (NCT06839235) dose escalation ongoing with ...
The effect of family history on adherence to breast cancer screening guidelines. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I. This abstract does not include a full text ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results